AusCann Group: Appoints Nick Woolf as CEO
- Medicinal cannabis company AusCann Group (AC8) has appointed Nick Woolf as CEO effective immediately
- Nick will be joining the company after a 25 year stint in the investment banking and life sciences industries, both in Australia and globally
- Previously, he was Chief Business Officer of Suda Pharmaceuticals (SUD), and Chief Financial Officer of PYC Therapeutics (PYC)
- After announcing his retirement in early May, previous CEO Ido Kanyon will end his time with AusCann at the end of August
- Ido joined the company more than 12 months ago from Teva Pharmaceuticals in the United States
- AusCann is up 5.17 per cent with shares trading for 15.3 cents each at 12:47 pm AEST
